ContributorsPublishersAdvertisers

Matt Kane

Raleigh News & Observer

Matt Kane plots ambitious return to Triangle biotech scene with Tune Therapeutics

N&O Innovation and Technology Newsletter: December 3, 2021. Enjoying the newsletter? Subscribe to it here, and share with your friends and colleagues. After successfully taking his last company, Precision Biosciences, to an IPO, Kane stepped down from Precision earlier this year. Now, he’s tackling a new frontier of gene therapy...
RALEIGH, NC
Picture for Matt Kane plots ambitious return to Triangle biotech scene with Tune Therapeutics